Your browser doesn't support javascript.
loading
Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) [Aktualizacja zalecen ogólnych dotyczacych postepowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych ukladu pokarmowego (rekomendowane przez Polska Siec Guzów Neuroendokrynnych)].
Kos-Kudla, Beata; Foltyn, Wanda; Malczewska, Anna; Bednarczuk, Tomasz; Bolanowski, Marek; Borowska, Malgorzata; Chmielik, Ewa; Cwikla, Jaroslaw B; Gisterek, Iwona; Handkiewicz-Junak, Daria; Hubalewska-Dydejczyk, Alicja; Jarzab, Barbara; Jarzab, Michal; Junik, Roman; Kajdaniuk, Dariusz; Kaminski, Grzegorz; Kolasinska-Cwikla, Agnieszka; Kowalska, Aldona; Królicki, Leszek; Krzakowski, Maciej; Kunikowska, Jolanta; Kusnierz, Katarzyna; Lewinski, Andrzej; Liszka, Lukasz; Londzin-Olesik, Magdalena; Marek, Bogdan; Nasierowska-Guttmejer, Anna; Nowakowska-Dulawa, Ewa; Pavel, Marianne E; Pilch-Kowalczyk, Joanna; Regula, Jaroslaw; Rosiek, Violetta; Ruchala, Marek; Rydzewska, Grazyna; Sieminska, Lucyna; Sowa-Staszczak, Anna; Starzynska, Teresa; Stojcev, Zoran; Strzelczyk, Janusz; Studniarek, Michal; Syrenicz, Anhelli; Szczepkowski, Marek; Wachula, Ewa; Zajecki, Wojciech; Zemczak, Anna; Zgliczynski, Wojciech; Zieniewicz, Krzysztof.
Afiliación
  • Kos-Kudla B; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Foltyn W; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland. wandafoltyn@poczta.onet.pl.
  • Malczewska A; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Bednarczuk T; Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland.
  • Bolanowski M; Chair and Department of Endocrinology, Diabetes, and Isotope Therapy, Medical University of Wroclaw, Wroclaw, Poland.
  • Borowska M; Department of Endocrinology and Neuroendocrine Tumours, Medical University of Silesia, Katowice, Poland.
  • Chmielik E; Tumor Pathology Department, Maria Sklodowska-Curie Memorial National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Cwikla JB; Department of Cardiology and Internal Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.
  • Gisterek I; Chair of Oncology and Radiotherapy, Medical University of Silesia, Katowice, Poland.
  • Handkiewicz-Junak D; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial National Research Institute of Oncology, Gliwice Brench, Gliwice, Poland.
  • Hubalewska-Dydejczyk A; Chair and Department of Endocrinology, Jagiellonian University Medical College, Cracow, Poland.
  • Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial National Research Institute of Oncology, Gliwice Brench, Gliwice, Poland.
  • Jarzab M; Breast Unit, Maria Sklodowska-Curie Memorial National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Junik R; Department of Endocrinology and Diabetology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
  • Kajdaniuk D; Division of Pathophysiology, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Kaminski G; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine, Warsaw, Poland.
  • Kolasinska-Cwikla A; Department of Oncology and Radiotherapy, Maria Sklodowska-Curie Memorial National Research Institute of Oncology, Warsaw, Poland.
  • Kowalska A; Department of Endocrinology, Holycross Cancer Centre, Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
  • Królicki L; Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland.
  • Krzakowski M; Department of Lung Cancer and Thoracic Tumours, Maria Sklodowska-Curie Memorial, National Research Institute of Oncology, Warsaw, Poland.
  • Kunikowska J; Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland.
  • Kusnierz K; Department of Gastrointestinal Surgery, Medical University of Silesia, Katowice, Poland.
  • Lewinski A; Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland.
  • Liszka L; Department of Pathomorphology and Molecular Diagnostics, Medical University of Silesia, Katowice, Poland.
  • Londzin-Olesik M; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Marek B; Division of Pathophysiology, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Nasierowska-Guttmejer A; Faculty of Medicine, Lazarski University in Warsaw, Warsaw, Poland.
  • Nowakowska-Dulawa E; Department of Gastroenterology and Hepatology, Medical University of Silesia, Katowice, Poland.
  • Pavel ME; Department of Medicine 1, Endocrinology and Diabetology, Friedrich Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
  • Pilch-Kowalczyk J; Department of Radiology and Nuclear Medicine, Medical University of Silesia, Katowice, Poland.
  • Regula J; Department of Oncological Gastroenterology, Maria Sklodowska-Curie Memorial National Research Institute of Oncology, Warsaw, Poland.
  • Rosiek V; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Ruchala M; Department of Endocrinology, Metabolism and Internal Diseases, Medical University in Poznan, Poznan, Poland.
  • Rydzewska G; Department of Internal Medicine and Gastroenterology, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland.
  • Sieminska L; Division of Pathophysiology, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Sowa-Staszczak A; Chair and Department of Endocrinology, Jagiellonian University Medical College, Cracow, Poland.
  • Starzynska T; Department of Gastroenterology, Medical Pomeranian University in Szczecin, Szczecin, Poland.
  • Stojcev Z; Department of Oncology and Breast Diseases, Centre of Postgraduate Medical Education, Warsaw, Poland.
  • Strzelczyk J; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Studniarek M; Department of Radiology, Medical University of Gdansk, Gdansk, Poland.
  • Syrenicz A; Department of Endocrinology, Metabolic and Internal Diseases, Pomeranian Medical University, Szczecin, Poland.
  • Szczepkowski M; Clinical Department of Colorectal, General and Oncological Surgery, Centre of Postgraduate Medical Education, Warsaw, Poland.
  • Wachula E; Department of Clinical Oncology, Gdynia Oncology Centre of the Polish Red Cross Maritime Hospital, Gdynia, Poland.
  • Zajecki W; Department of Endocrinology and Neuroendocrine Tumours, Medical University of Silesia, Katowice, Poland.
  • Zemczak A; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Zgliczynski W; Department of Endocrinology, Centre of Postgraduate Medical Education, Warsaw, Poland.
  • Zieniewicz K; Chair and Department of General, Transplant, and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
Endokrynol Pol ; 73(3): 387-454, 2022.
Article en En | MEDLINE | ID: mdl-36059171
ABSTRACT
Continuous progress in the diagnostics and treatment of neuroendocrine neoplasms (NENs), the emerging results of new clinical trials, and the new guidelines issued by medical societies have prompted experts from the Polish Network of Neuroendocrine Tumours to update the 2017 recommendations regarding the management of neuroendocrine neoplasms. This article presents the general recommendations for the management of NENs, resulting from the findings of the experts participating in the Fourth Round Table Conference, entitled "Polish Guidelines for the Diagnostics and Treatment of Neuroendocrine Neoplasms of the gastrointestinal tract, Zelechów, June 2021". Drawing from the extensive experience of centres treating these cancers, we hope that we have managed to formulate the optimal method of treating patients with NENs, applying the latest reports and achievements in the field of medicine, which can be effectively implemented in our country. The respective parts of this work present the approach to the management of NENs of the stomach and duodenum (including gastrinoma), pancreas, small intestine, and appendix, as well as large intestine.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tumores Neuroendocrinos / Endocrinología Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Endokrynol Pol Año: 2022 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tumores Neuroendocrinos / Endocrinología Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Endokrynol Pol Año: 2022 Tipo del documento: Article País de afiliación: Polonia